137 | IBRUTINIB ADDED TO MCL TREATMENT HAS STRONG IMPACT ON MRD RESPONSE AND DISEASE KINETICS: RESULTS FROM THE TRIANGLE TRIAL M. Khouja,V. Jurinovic,S. Ferrero,E. Genuardi,B. Kehden, A. M. Civita,C. U. Niemann,R. García Sanz, A. M. Herrera, C. Homburg, O. J. Verhagen, V. H. van der Velden, S. Kubetzko,E. Fronkova,P. Gameiro,C. Schmidt,J. K. Doorduijn,E. Gine, M. Jerkemann,M. Hutchings,J. Walewski, J. Riise,U. J. Mey,M. Trneny, V. K. Vergote,O. Shpilberg, M. Gomes da Silva,S. Leppä,M. Unterhalt,W. Klapper,E. Hoster, M. Dreyling,M. Ladetto,C. Pott